PDCD1LG2 and head and neck squamous cell carcinoma: The expression of immune-checkpoints, including CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, TIGIT, and SIGLEC15 (Fig. 6A), were further investigated in the World Health Organization (WHO) grade II and III of HNSCC.